According to the Regional Research Reports, the global prostate cancer diagnostics market size was estimated to grow at a CAGR of 12.3% during the forecast period.
Prostate cancer often shows no symptoms till the disease is advanced; though, a screening help detect prostate cancer at an early stage, when the chances of treatment failure are low. It is usually performed by a urologist, using a core needle biopsy, which is one of the main methods used to diagnose prostate cancer. During the biopsy, the urologist observes a prostate with an imaging test, including transrectal ultrasound (TRUS) or MRI, or both.
This report contains the market size and forecasts of Prostate Cancer Diagnostics in the global market, including the following market information:
- Global Prostate Cancer Diagnostics Market Revenue, 2018-2021, 2022-2030, (US$ Millions)
- Global top five Prostate Cancer Diagnostics companies in 2021 (%)
Regional Research Reports has surveyed the Prostate Cancer Diagnostics manufacturers, suppliers, distributors, and industry experts in this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnostics Market, By Test Type, 2018-2021, 2022-2030 (US$ Millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, By Test Type, 2021 (%)
- Preliminary Tests
- Confirmatory Tests
- PCA3 Tests
- Trans-rectal Ultrasound
- Biopsy
Global Prostate Cancer Diagnostics Market, By Age, 2018-2021, 2022-2030 (US$ Millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, By Age, 2021 (%)
- Hospital Associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
- Others
Global Prostate Cancer Diagnostics Market, By Region and Country, 2018-2021, 2022-2030 (US$ Millions)
Global Prostate Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America (US, Canada, Mexico)
- South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
- Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
- Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
- The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)
Competitor Analysis of the Global Prostate Cancer Diagnostics Market
The report also provides an analysis of leading market participants, including:
- Key companies Prostate Cancer Diagnostics revenues in global market, 2018-2021 (Estimated), (US$ Millions)
- Key companies Prostate Cancer Diagnostics revenues share in global market, 2021 (%)
- Key companies Prostate Cancer Diagnostics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market; key players include:
- F. Hoffman-La Roche AG
- Abbott Laboratories
- Genomic Health
- Gregor Diagnostics
- OPKO Health, Inc
- Diagnolita
- Siemens Healthcare GmbH
- Caldera Health
- Minomic
- Myriad Genetics, Inc.
- MDx Health
- Myriad Genetics, Inc.
- Exosome Diagnostics
Key Questions Answered in This Report:
- What will the market forecast and the growth rate from 2022 to 2030?
- What are the top driving elements of the industry?
- What are the key trends and dynamics of the market?
- What are the obstacles developed to the market?
- How much can incremental dollar investment opportunities be witnessed in the market over the forecast period?
- Who are the leading companies with their market positioning share?
- Analysis of the companies and the market through SWOT, PORTER's, and PESTEL study.
Why do you need to purchase this report?
- Identify the market shares, latest developments, and strategies of the major market players
- Determine the prospective investment areas based on the detailed trend examination of the global market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different market segments in the top spending countries worldwide and identify their opportunities.
- Strengthen your market understanding regarding demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the global market, providing a clear picture of the future opportunities that can be tapped, and resulting in revenue expansion.
- Channelize capitals by focusing on the ongoing programs undertaken by the different countries within the global market.
- 3-months of analyst support, along with the Market Estimate sheet (in excel)
